On September 25, 2023 Bexion Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company developing a new generation of biologic therapy to treat solid tumor cancers and chemotherapy-induced peripheral neuropathy (CIPN), reported that the Company will participate in the 2023 Cantor Global Healthcare Conference (Press release, Bexion, SEP 25, 2023, View Source [SID1234635376]). The conference will be held in New York, NY, from September 26-28, 2023.

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!

Scott Shively, CEO and President of Bexion Pharmaceuticals, will be presenting a company overview at the conference on September 27, 2023, at 4:45 – 5:15 p.m. ET in Track 2.